A detailed history of Mountain Pacific Investment Advisers Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 17,608 shares of ABBV stock, worth $3.09 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
17,608
Previous 16,708 5.39%
Holding current value
$3.09 Million
Previous $2.87 Million 21.36%
% of portfolio
0.24%
Previous 0.22%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $147,456 - $179,397
900 Added 5.39%
17,608 $3.48 Million
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $109,281 - $127,616
-706 Reduced 4.05%
16,708 $2.87 Million
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $47,946 - $54,630
-300 Reduced 1.69%
17,414 $3.17 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $20,640 - $23,245
-150 Reduced 0.84%
17,714 $2.75 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $36,603 - $42,374
-274 Reduced 1.51%
17,864 $2.66 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $39,753 - $49,470
-300 Reduced 1.63%
18,138 $2.44 Million
Q1 2023

May 23, 2023

SELL
$144.61 - $166.54 $130,149 - $149,886
-900 Reduced 4.65%
18,438 $2.94 Million
Q4 2022

Jan 20, 2023

SELL
$138.31 - $165.87 $39,556 - $47,438
-286 Reduced 1.46%
19,338 $0
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $49,523 - $56,800
-369 Reduced 1.85%
19,624 $2.63 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $104,866 - $133,319
-762 Reduced 3.67%
19,993 $3.06 Million
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $22,436 - $27,837
-170 Reduced 0.81%
20,755 $3.37 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $161,145 - $203,895
-1,500 Reduced 6.69%
20,925 $2.83 Million
Q3 2021

Oct 25, 2021

SELL
$106.4 - $120.78 $73,735 - $83,700
-693 Reduced 3.0%
22,425 $2.42 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $76,908 - $85,680
-731 Reduced 3.07%
23,118 $2.6 Million
Q1 2021

Apr 14, 2021

SELL
$102.3 - $112.62 $7,263 - $7,996
-71 Reduced 0.3%
23,849 $2.58 Million
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $13,119 - $17,713
-163 Reduced 0.68%
23,920 $2.56 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $48,882 - $57,372
569 Added 2.42%
24,083 $2.11 Million
Q2 2020

Jul 09, 2020

SELL
$73.37 - $98.18 $7,850 - $10,505
-107 Reduced 0.45%
23,514 $2.31 Million
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $52,890 - $80,187
820 Added 3.6%
23,621 $1.8 Million
Q2 2019

Jul 23, 2019

BUY
$65.7 - $83.98 $25,360 - $32,416
386 Added 1.72%
22,801 $1.66 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $23,142 - $27,237
-300 Reduced 1.32%
22,415 $1.81 Million
Q4 2018

Jan 25, 2019

SELL
$77.85 - $96.01 $25,301 - $31,203
-325 Reduced 1.41%
22,715 $2.09 Million
Q1 2018

Apr 30, 2018

SELL
$92.01 - $123.21 $2.12 Million - $2.84 Million
-23,040 Closed
0 $0
Q4 2017

Jan 23, 2018

SELL
$89.56 - $98.21 $13,434 - $14,731
-150 Reduced 0.65%
23,040 $2.23 Million
Q3 2017

Oct 20, 2017

BUY
$69.85 - $89.22 $1.62 Million - $2.07 Million
23,190
23,190 $2.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.